首页> 外文OA文献 >A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial

【2h】

A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial

机译：一项多中心，随机，双盲安慰剂对照试验，评估罗格列酮对2型糖尿病患者冠状动脉搭桥术后动脉粥样硬化进展的预防作用。旁路手术（VICTORY）试验后静脉静脉粥样硬化和罗格列酮的设计和原理

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Bertrand, Olivier F; Poirier, Paul; Rodés-Cabau, Josep; Rinfret, Stéphane; Title, Lawrence; Dzavik, Vladimir; Natarajan, Madhu; Angel, Juan; Batalla, Nuria; Alméras, Natalie; Costerousse, Olivier; De Larochellière, Robert; Roy, Louis; Després, Jean-Pierre;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. [J] . Bertrand OF, Poirier P, Rodes Cabau J The Canadian journal of cardiology . 2009,第9期

机译：一项多中心，随机，双盲安慰剂对照试验，评估罗格列酮对2型糖尿病患者冠状动脉搭桥术后动脉粥样硬化进展的预防作用。旁路手术（VICTORY）试验后静脉静脉粥样硬化和罗格列酮的设计和原理。
2. Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial. [J] . Bertrand OF, Poirier P, Rodes Cabau J, Atherosclerosis . 2010,第2期

机译：罗格列酮对2型糖尿病和冠状动脉搭桥术患者的心脏代谢作用：一项随机安慰剂对照临床试验。
3. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial [J] . de Waha Antoinette, Sandner Sigrid, von Scheidt Moritz, The American heart journal . 2016,第期

机译：随机，平行群，TiCagreloR的双盲研究与阿司匹林预防冠心动脉旁路移植手术患者的血管事件：CABG（TICAB）试验中TicagreloR的理由和设计：调查员启动的试验
4. Monocyte chemotactic protein-1 and E-selectin inflammatory patterns in coronary artery bypass graft surgery with the miniaturized extracorporeal circulation: a randomized clinical trial [C] . Mariani S., Formica F., Broccolo F., International Congress on Coronary Artery Disease. . 2013

机译：单核细胞趋化蛋白-1和冠状动脉旁路移植手术中的e-Selectin炎性模式，具有小型化体外循环：随机临床试验
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. A multicentre randomized double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial [O] . Olivier F Bertrand, Paul Poirier, Josep Rodés-Cabau, 2009

机译：一项多中心随机双盲安慰剂对照试验评估罗格列酮对2型糖尿病患者冠状动脉搭桥术后动脉粥样硬化进展的预防作用。旁路手术（VICTORY）试验后静脉静脉粥样硬化和罗格列酮的设计和原理
7. Hypotheses, rationale, design, and methods for evaluation of a randomized controlled trial using Tocotrienol, an isomer of Vitamin E derived from palm oil, on the prevention of atrial fibrillation after coronary artery bypass grafting surgery [O] . Ahmad Farouk Musa, Jeswant Dillon, Mohamed Ezani Md Taib, 2018

机译：使用Tocotrienol评估随机对照试验的假设，理由，设计和方法，其来自棕榈油的维生素E的异构体，在冠状动脉旁路移植手术后预防心房颤动

著录项

相似文献

相关主题

期刊订阅